WASHINGTON, Feb. 28, 2022 (GLOBE NEWSWIRE) — The Global Medical Polymers Market size is expected to reach USD 32.5 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period. Medical Polymers are used in the manufacturing of medical devices and packaging, the sturdy growth in pharmaceuticals in past years led to an increased demand for Medical Polymers and subsequently boosting the marker growth, states Vantage Market Research, in a report, titled “Medical Polymers Market by Product (Medical resins & fibers, Medical elastomers, Biodegradable plastics), by Application (Medical equipment & devices, Medical packaging, Others), by Region (North America, Europe, Asia-Pacific, Latin America) – Global Industry Assessment (2016 – 2021) & Forecast (2022 – 2028)”. The market size valued at USD 16.5 Billion in 2021.
Please Check Out Our Free Sample Reports and Make a More Informed Decision:
Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/medical-polymers-market-1210/request-sample
(Sample reports are a great way to test our in-depth reports or study before you make a purchase)
The newly updated, 160+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.
Using industry data and interview with experts, you can learn about topics such as regional impact analysis, global forecast, competitive landscape analysis, size & share of regional markets.
We offer these reports in PDF format so you can read them on your computer and print them out.
Free sample includes, Industry Operating Conditions, Industry Market Size, Profitability Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast, Growth Porter's 5 Forces Analysis, Revenue Forecasts, Industry Trends, Industry Financial Ratios.
The report also presents the country-wise and region-wise analysis of the Vantage Market Research and includes a detailed analysis of the key factors affecting the growth of the market.
Sample Report further sheds light on the Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis, to offer the readers an advantage over others.
List of Prominent Players in the Medical Polymers Market:
Evonik Industries AG
DSM N.V.
BASF SE
Celanese Corporation
Eastman Chemical
Exxon Mobil Corporation
Kraton Performance Polymers Inc.
Formosa Plastics Corporation
Market Dynamics:
Government Initiatives to Boost the Pharmaceutical Sector
Government organizations in countries are taking initiatives for growth and development of pharmaceutical sector by investing in R&D activities to come up with technically advanced equipment, helping in eradicating fatal diseases around the globe is expected to positively influence the Medical Polymers Market demand during the forecast period. Additionally, shifting preference of patients toward the homecare health treatment as they are cost-effective as well as convenient in nature has resulted in high demand for medical disposables worldwide. These factors will contribute in attaining higher market share during the forecast period.
Purchase This Premium Report Now @ https://www.vantagemarketresearch.com/buy-now/medical-polymers-market-1210/1
Benefits of Purchasing Medical Polymers Market Reports:
Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
Assured Quality: Focuses on accuracy and quality of reports.
Incomparable Skills: Analysts provide in-depth insights into reports.
Technological Advancements to Fuel the Market Growth
Higher application of fibers and resins in the Medical Polymers Market is resulting as their excellence in carrying out the artificial implants as well as higher biocompatibility of the product coupled with improving surgical procedures need advanced medical devices & equipment are factors accelerating market growth. On the other side, price fluctuations in raw material and presence of stringent rules & regulations related to usage of polymers are factors expected to hinder the market growth.
COVID-19 Impact Analysis
The COVID-19 outbreak has affected various industries worldwide. Governments across the world implemented strict lockdown measures and social distancing norms in order to restrict the swift spread of the pandemic. Manufacturing facilities around the world were shut down during the initial stages of the pandemic. Moreover, the economic crisis after the pandemic might lead to a significant delay in the commercial roll-out of the chemical industry. Small and medium-scale companies are the backbone of technology providers and are witnessing a steep drop in revenue since the emergence of the pandemic in 2020. Hence, market players faced numerous challenges as disruptions in the supply chain were observed. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data points:
Impact Assessment of COVID-19 Pandemic
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Quarterly Market Revenue Forecast by Asia Pacific 2020 & 2021
Key Strategies Undertaken by Companies to Tackle COVID-19
Long Term Dynamics
Short Term Dynamics
Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/medical-polymers-market-1210
The report on Medical Polymers Market highlights:
Assessment of the market
Premium Insights
Competitive Landscape
COVID Impact Analysis
Historic Data, Estimates and Forecast
Company Profiles
Global and Regional Dynamics
Regional Analysis:
North America Dominates the Global Medical Polymers Market
North America is witnessed higher market share in 2021. This is owing to the increasing awareness for personal healthcare and hygiene. With this, the presence of key players like The Lubrizol Corporation, Formosa Plastics Corporation, U.S.A., and Kraton Corporation and substantial investments in R&D are factors boosting market demand. The demand from end user industries is rising and likely to enhance the Medical Polymers Market in the region.
Recent Developments:
December 2021: SABIC has launched a new portfolio of biobased ULTEM resins that offer sustainability benefits while delivering the same high performance and processability as incumbent ULTEM materials.
January, 2022: Ampacet, a global masterbatch leader, has introduced ProVital+ Colors, a range of medical-grade colour solutions specifically designed for pharmaceutical packaging, medical devices and in-vitro diagnostic equipment. In addition to the standard ProVital+ Colors range, custom solutions can be designed with the pre-tested pigments and different polymers.
Browse market data Tables and Figures spread through 169 Pages and in-depth TOC on "Medical Polymers Market by Product (Medical resins & fibers, Medical elastomers, Biodegradable plastics), by Application (Medical equipment & devices, Medical packaging, Others), by Region (North America, Europe, Asia-Pacific, Latin America) – Global Industry Assessment (2016 – 2021) & Forecast (2022 – 2028)" View detailed Research Report here – https://www.vantagemarketresearch.com/press-release/medical-polymers-market-056270
Key questions answered in the report:
Which regional market will show the highest and rapid growth?
Which are the top five players of the Medical Polymers Market?
How will the Medical Polymers Market change in the upcoming six years?
Which application and product will take a lion’s share of the Medical Polymers Market?
What is the Medical Polymers market drivers and restrictions?
What will be the CAGR and size of the Medical Polymers Market throughout the forecast period?
This market titled “Medical Polymers Market” will cover exclusive information in terms of Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:
Report Attribute
Details
Market Size in 2021
USD 16.5 Billion
Projected Market Size in 2028
USD 32.5 Billion
CAGR Growth Rate
CAGR of 9.3% From 2022 – 2028
Base Year
2021
Historic Years
2016 – 2020
Forecast Years
2022 – 2028
Segments Covered
Product: – Medical Resins & Fibers, Medical Elastomers, Biodegradable Plastics
Application: – Medical Equipment & Devices, Medical Packaging, Others
Quantitative Data – Units
Revenue in USD Million/Billion and CAGR from 2022 to 2028
Regions Covered
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Countries Covered
U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Report Coverage
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization of the Report:
The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.
Download Free Sample Report Now @ https://www.vantagemarketresearch.com/medical-polymers-market-1210/request-sample
Browse More Related Report:
Fumed Silica Market:- https://www.vantagemarketresearch.com/industry-report/fumed-silica-market-1209
Lactic Acid Market:- https://www.vantagemarketresearch.com/industry-report/lactic-acid-market-1150
Tartaric Acid Market:- https://www.vantagemarketresearch.com/industry-report/tartaric-acid-market-1143
Calcium Propionate Market:- https://www.vantagemarketresearch.com/industry-report/calcium-propionate-market-1089
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/
Follow Us on Twitter: https://twitter.com/vantagemarketr
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 – 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: sales@vantagemarketresearch.com
Website: https://www.vantagemarketresearch.com/
Latest Vantage Market Research Press Releases @ https://www.vantagemarketresearch.com/insight/press-releases
Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs
Blog:
https://bwsc.kr/
https://makitirapide.com/
https://www.globalresearchwire.com/
https://marketstrades.com/
https://v-mr.biz/
Several factors have come together that have scared investors out of Rivian Automotive (NASDAQ: RIVN) stock this week. In just the past two days, Rivian shares have plunged almost 20%. The electric vehicle (EV) start-up will provide its operational and financial update next week, and investors are worried about what they'll hear.
Shares of defense contracting pure play Lockheed Martin (NYSE: LMT) — which got quite a lift on Tuesday after Germany announced plans to triple its 2022 defense budget, and Wolfe Research upgraded LockMart stock in response — is giving back its gains on Wednesday. As of 10 a.m. ET, Lockheed Martin stock is down 4.4%. Why is Lockheed Martin stock — a defense stock, let's not forget, in a time of conflict in Europe — down?
Wall Street begins to weigh in on a major transformation just unveiled at Ford.
Shares of clinical-stage immunotherapy company Agenus (NASDAQ: AGEN) were up by a healthy 18% as of 1:09 p.m. ET on Wednesday. What appears to really be moving the stock, though, is a price target upgrade by financial firm H.C. Wainwright. In response to the impressive clinical progress of Agenus' anti-cancer checkpoint inhibitor platform, Wainwright raised its 12-month price target on the biotech's shares to $14 ahead of the opening bell this morning.
Believe it or not, markets remain focused on another key issue besides the war between Russia and Ukraine.
While there’s no magic number as to the amount of money someone should have in savings, experts agree that at least having an emergency fund — anywhere from 3-to-9 months of expenses — in savings is imperative. But accounts with higher APYs do exist.
What happened Shares of Pfizer (NYSE: PFE) were up by 4% as of 12:08 p.m. ET Wednesday. The drugmaker's stock is rising today in response to two separate catalysts. First up, President Joe Biden's Test to Treat initiative, announced during his State of the Union address on Tuesday, ought to be a boon for Pfizer's oral COVID-19 pill Paxlovid.
Karyopharm Therapeutics Inc (NASDAQ: KPTI) stock plunged after an update on its supplemental New Drug Application submission based on the Phase 3 SIENDO study data of selinexor as front-line maintenance therapy following chemotherapy in advanced or recurrent endometrial cancer. The cmpany received feedback that the current SIENDO study topline results would not support an sNDA approval. Karyopharm and the FDA participants had differing views on the study significance and overall clinical benefit
Novavax (NASDAQ: NVAX) missed Wall Street's revenue estimate in the fourth quarter of 2021. As proof, the vaccine maker's shares rose on Tuesday after Novavax's Q4 update following the market close on Monday. Here are two numbers that should especially make Novavax shareholders smile.
Some Russian companies have recently been valued at more than $100 billion. Sberbank, the country's biggest bank. traded for a penny in London.
There are plenty of fundamentally sound, low cost stocks out there for retail investors to consider. The key to success is to find stocks that are at or near the bottom of their cycle. Equity investment advisors will always tell you that ‘timing the market’ is impossible, and they’re right – but timing is still important for success. Investors need to buy into low prices, and to do that, they need to know when prices are low. This doesn’t necessarily mean low in absolute dollar terms, but low re
McDonald's franchisees, for example, pushed back against the chain's legendary dollar menu to the point that corporate had to revamp it into the current $1, $2, $3 menu. If a restaurant owner was already upset at the price being charged for low-end hamburgers and chicken nuggets or various other value offerings, they're likely to be very angry as those items cost them more in the first place. Now, Restaurant Brands International's Burger King's largest franchise owner has decided to do something about its rising costs and customers are not going to like it.
Yahoo Finance's Brian Sozzi and Julie Hyman discuss news that Ford will separate its electric vehicle and internal combustion engine businesses.
The 5G equipment maker was accused of violating a past corruption settlement agreement with the U.S. Department of Justice.
Yahoo Finance's Brian Sozzi and Julie Hyman discuss why Nordstrom stock is soaring after the company reported earnings.
Investors lost confidence in Roblox (NYSE: RBLX) in the second month of 2022 after the company reported underwhelming revenue and user growth for the fourth quarter of 2021. According to data from S&P Global Market Intelligence, shares of the gaming platform dropped 21.7% in February. On Feb. 15, Roblox released its earnings report for Q4 2021.
Investors in Plug Power (NASDAQ: PLUG) are having a good week so far. Optimism in the hydrogen fuel cell stock soared ahead of earnings, fueled by rising oil prices that turned the market's focus to alternative fuel technologies like hydrogen and fuel cells. Plug Power stock extended its gains this morning and rose 2.7% as of 11:10 a.m. ET as the market reacted positively to the company's fourth-quarter numbers and outlook for 2022, released on March 1 after market close.
Caterpillar Inc. ( NYSE:CAT ) received a lot of attention from a substantial price movement on the NYSE over the last…
Shares of Hewlett Packard Enterprise (NYSE: HPE) stock roared ahead 10.8% through 1 p.m. ET on Wednesday after the cloud computing company announced earnings last night that beat Wall Street's earnings estimates with a stick. Heading into its fiscal first quarter of 2022, analysts had forecast that Hewlett Packard Enterprise (HPE) would earn $0.46 per share (adjusted) on sales of $7 billion. As it turned out, HPE only needed $7 billion in sales to earn $0.53 per share — 15% ahead of expectations.
(Bloomberg) — U.K.-listed depositary receipts of Russian companies are evaporating in value as sanctions take effect. Most Read from BloombergChina Holds Talks With Ukraine, Further Edging Away From RussiaBlinken to Travel to Baltics, Poland This Week: Ukraine UpdateChina Spy Think Tank Advising Xi Predicts Russia Sanctions Will BackfireTeen Who Tracked Elon Musk’s Jet Is Now Chasing Russian TycoonsBiden Assails Putin, Pledges Inflation Fight in State of UnionThe Dow Jones Russia GDR Index, whi
